Clinical Trial Update: HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update comparing HS-IT101 injection to chemotherapy for advanced melanoma (excluding uveal melanoma) is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• HS-IT101

Snippet

Sponsor: Qingdao Sino-Cell Biomedicine Co., Ltd. | Conditions: Melanoma (Excluding Uveal Melanoma) | Phase 2 | Status: NOT_YET_RECRUITING